Blood and fluid management during scoliosis surgery: a single-center retrospective analysis.

Koraki, Eleni; Stachtari, Chrysoula; Stergiouda, Zoi; Stamatopoulou, Maria; Gkiouliava, Anna; Sifaki, Freideriki; Chatzopoulos, Stavros; Trikoupi, Anastasia · Eur J Orthop Surg Traumatol · 2020

retrospective_cohort · Level III

Where this comes from

Abstract

In the present retrospective study in scoliosis surgery, we hypothesized that application of a protocol for blood and fluid management, based on goal-directed fluid therapy, cell salvage and tranexamic acid, could lead to reduced allogeneic red blood cells transfusion. Thirty-five patients, with American Society of Anesthesiologists physical status I/III, between 14 and 18 years scheduled for elective orthopedic surgery of scoliosis, with a planned intensive care unit admission, were enrolled in a retrospective observational study. Patients were divided in two groups. Patients in no-protocol group (Group noPro, n = 18) received a liberal intraoperative fluid therapy and patients in protocol group (Group Pro, n = 17) received fluid therapy managed according to a stroke volume variation-based protocol. The protocol included fluid therapy according to SVV monitor, permissive hypotension, tranexamic acid infusion, restrictive RBC trigger and use of perioperative cell savage. Student's t test (2-tailed), Mann-Whitney test, Chi square test were used for statistical analysis of the data. There were no significant differences between the two groups in demographic data and clinical characteristics. Infused crystalloids (p = .003) and transfused allogeneic red blood cells (p = .015) were lesser in Group Pro compared to Group noPro. On the other hand, diuresis (p < .001) and vasopressors administration (p = .042) were higher in Group Pro than in Group noPro. The application of a protocol for blood and fluid management, based on goal-directed fluid therapy, cell salvage and tranexamic acid, was associated with less crystalloid fluid administration, less perioperative RBC transfusions and significantly better diuresis than patients in the no-protocol group in scoliosis surgery. ClinicalTrials.gov Identifier: NCT03814239.

Medical subject headings